Arbutus to Present at Jefferies London Healthcare Conference
14. November 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
Arbutus to Present at Jefferies London Healthcare Conference
08. November 2023 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
Arbutus to Present at Jefferies London Healthcare Conference
08. November 2022 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...
Esperion to Participate in Jefferies London Healthcare Conference
02. November 2022 08:00 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that President and CEO, Sheldon Koenig, will present at the Jefferies London Healthcare Conference on...
Esperion to Participate in Fireside Chat at the Jefferies 2017 London Healthcare Conference
13. November 2017 16:30 ET
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary,...